{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Crohn's disease Adalimumab prior authorization criteria","id":"q1"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Adalimumab treatment guidelines for Crohn's disease","id":"q2"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Prior authorization requirements for Adalimumab in inflammatory bowel disease","id":"q3"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Adalimumab therapy approval for Crohn's disease","id":"q4"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Inflammatory bowel disease Adalimumab authorization policy","id":"q5"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Adalimumab usage criteria for Crohn's disease","id":"q6"}
{"diagnosis":"Inflammatory Bowel Disease (Crohn\u2019s)","medication":"Adalimumab","title":"001.pdf","query":"Crohn's Adalimumab medication authorization guidelines","id":"q7"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Lennox-Gastaut Syndrome Epidiolex prior authorization criteria","id":"q8"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Epidiolex treatment guidelines for Lennox-Gastaut Syndrome","id":"q9"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Prior authorization requirements for Epidiolex in Lennox-Gastaut","id":"q10"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Epidiolex therapy approval for Lennox-Gastaut Syndrome","id":"q11"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Lennox-Gastaut Syndrome Epidiolex medication authorization policy","id":"q12"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Epidiolex usage criteria for Lennox-Gastaut Syndrome","id":"q13"}
{"diagnosis":"Lennox-Gastaut Syndrome","medication":"Epidiolex","title":"002.pdf","query":"Authorization guidelines for Epidiolex in Lennox-Gastaut Syndrome","id":"q14"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Philadelphia chromosome-negative B-ALL Blinatumomab prior authorization criteria","id":"q15"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Blinatumomab treatment guidelines for Philadelphia chromosome-negative lymphoblastic leukemia","id":"q16"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Prior authorization requirements for Blinatumomab in B-ALL Philadelphia chromosome-negative","id":"q17"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Blinatumomab therapy approval for Philadelphia chromosome-negative B-ALL","id":"q18"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Philadelphia chromosome-negative lymphoblastic leukemia Blinatumomab authorization policy","id":"q19"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Blinatumomab usage criteria for Philadelphia chromosome-negative B-ALL","id":"q20"}
{"diagnosis":"Lymphoblastic Leukemia (B-ALL), Philadelphia chromosome-negative","medication":"Blinatumomab","title":"003.pdf","query":"Authorization guidelines for Blinatumomab in Philadelphia chromosome-negative leukemia","id":"q21"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Severe atopic dermatitis Dupilumab prior authorization criteria","id":"q22"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Dupilumab treatment guidelines for severe atopic dermatitis","id":"q23"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Prior authorization requirements for Dupilumab in atopic dermatitis","id":"q24"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Dupilumab therapy approval for severe atopic dermatitis","id":"q25"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Severe eczema Dupilumab authorization policy","id":"q26"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Dupilumab usage criteria for severe atopic dermatitis","id":"q27"}
{"diagnosis":"Severe Atopic Dermatitis","medication":"Dupilumab","title":"004.pdf","query":"Authorization guidelines for Dupilumab in severe atopic dermatitis","id":"q28"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"High-grade osteosarcoma Everolimus prior authorization criteria","id":"q29"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"Everolimus treatment guidelines for high-grade osteosarcoma","id":"q30"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"Prior authorization requirements for Everolimus in osteosarcoma","id":"q31"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"Everolimus therapy approval for high-grade osteosarcoma","id":"q32"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"High-grade osteosarcoma Everolimus medication authorization policy","id":"q33"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"Everolimus usage criteria for high-grade osteosarcoma","id":"q34"}
{"diagnosis":"High-grade Osteosarcoma","medication":"Everolimus","title":"005.pdf","query":"Authorization guidelines for Everolimus in high-grade osteosarcoma","id":"q35"}
